Catalyst Wire Dossier Catalyst Wire Dossier

DILAUDID

Hydromorphone hydrochloride · Rhodes Pharmaceuticals L.P.
Drug timelines are a Plus or Pro feature.

27 regulatory and trial events tracked for DILAUDID, covering 2006-06-12 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: DILAUDID — Supplemental Application (Rhodes Pharmaceuticals L.P.)

See pricing